Lack of evidence for exposure-response relationship in the use of posaconazole as prophylaxis against invasive fungal infections

Clin Pharmacol Ther. 2011 Mar;89(3):351-2. doi: 10.1038/clpt.2010.261. Epub 2011 Jan 26.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antifungal Agents / administration & dosage
  • Antifungal Agents / pharmacokinetics
  • Antifungal Agents / therapeutic use*
  • Clinical Trials as Topic
  • Dose-Response Relationship, Drug
  • Humans
  • Mycoses / prevention & control*
  • Treatment Outcome
  • Triazoles / administration & dosage
  • Triazoles / pharmacokinetics
  • Triazoles / therapeutic use*

Substances

  • Antifungal Agents
  • Triazoles
  • posaconazole